EC-18, a synthetic monoacetyldiacylglyceride, inhibits hematogenous metastasis of KIGB-5 biliary cancer cell in hamster model

Journal of Korean Medical Science

Volumn 24, Issue 3, 2009, Pages 474-480

  Kim, Myung Hwan ^a   Chang, Heung Moon ^a   Kim, Tae Won ^a   Lee, Sung Koo ^a   Park, Jung Sun ^b   Kim, Young Hoon ^b   Lee, Tae Yoon ^a   Jang, Se Jin ^a   Suh, Chul Won ^a   Lee, Tae Suk ^c   Kim, Sang Hee B ^b   Lee, Sung Gyu ^a  

^a University of Ulsan College of Medicine   (South Korea)

^b Asan Institute for Life Sciences   (South Korea)

^c R and D Center   (South Korea)

Author keywords

Anti tumor effect; Biliary cancer; EC 18; TLR 4

Indexed keywords

1 PALMITOYL 2 LINOLEOYL 3 ACETYL RAC GLYCEROL; 1-PALMITOYL-2-LINOLEOYL-3-ACETYL-RAC GLYCEROL; ACYLGLYCEROL; ANTINEOPLASTIC AGENT; CYTOKINE; TOLL LIKE RECEPTOR 4;

ANIMAL; ARTICLE; BILIARY TRACT TUMOR; FEMALE; GENETICS; HAMSTER; IMMUNOLOGY; LUNG; METABOLISM; METASTASIS; PATHOLOGY; T LYMPHOCYTE; TUMOR CELL CULTURE;

ANIMALS; ANTINEOPLASTIC AGENTS; BILIARY TRACT NEOPLASMS; CRICETINAE; CYTOKINES; FEMALE; GLYCERIDES; LUNG; NEOPLASM METASTASIS; T-LYMPHOCYTES; TOLL-LIKE RECEPTOR 4; TUMOR CELLS, CULTURED;

EID: 67649204442     PISSN: 10118934     EISSN: 15986357     Source Type: Journal    
DOI: 10.3346/jkms.2009.24.3.474     Document Type: Article

References (20)

1. Lazaridis KN, Gores GJ. Cholangiocarcinoma. Gastroentrology 2005; 128: 1655-67.
2. Olnes MJ, Erlich R. A review and update on cholangiocarcinoma. Oncology 2004; 66: 167-79.
3. Rosenberg SA, Yang JC, Topalian SL, Schwartzentruber DJ, Weber JS, Parkinson DR, Seipp CA, Einhorn JH, White DE. Treatment of 283 consecutive patients with metastatic melanoma or renal cancer using high dose bolus interleukin-2. JAMA 1994; 271: 907-13.
4. Yang HO, Kim SH, Cho SH, Kim MG, Seo JY, Park JS, Jhon GJ, Han SY. Purification and structural determination of hematopoietic stem cell-stimulating monoacetyldiglycerides from Cervus nippon (deer antler). Chem Pharm Bull 2004; 52: 874-8.
5. Yang HO, Park JS, Cho SH, Yoon JY, Kim MG, Jhon GJ, Han SY, Kim SH. Stimulatory effects of monoacetyldiglycerides on hematopoiesis. Biol Pharm Bull 2004; 27: 1121-5.
6. Kim MH, Lee SS, Lee SK, Lee SG, Suh CW, Gong GY, Park JS, Kim YH, Kim SH. Interleukin-2 gene-encoded stromal cells inhibit the growth of metastatic cholangiocarcinomas. World J Gastroenterol 2006; 12: 1889-94.
7. Huang B, Zhao J, Li H, He KL, Chen Y, Chen SH, Mayer L, Unkeless JC, Xiong H. Toll-like receptors on tumor cells facilitate evasion of immune surveillance. Cancer Res 2005; 65: 5009-14.
8. Korean patent application 10-2005-0065792 (2005. 7. 20).
9. Dimaio TA, Wang S, Huang Q, Scheef EA, Sorenson CM, Sheibani N. Attenuation of retinal vascular development and neovascularization in PECAM-1-deficient mice. DEV BIO 2008; 315: 72-88.
10. Hillman GG, Younes E, Visscher D, AIi E, Lam JS, Montecillo E, Pontes JE, Haas GP, Puri RK. Systemic treatment with interleukin-4 induces regression of pulmonary metastases in murine renal cell carcinoma model. Cell Immunol 1995; 160: 257-63.
11. Peace DJ, Kern DE, Schultz KR, Greenberg PD, Cheever MA. IL-4-induced lymphokine-activated killer cells. Lytic activity is mediated by phenotypically distinct natural killer-like and T cell-like large granular lymphocytes. J Immunol 1988; 140: 3679-85.
12. Gambacorti-Passerini C, Rivoltini L, Supino R, Rodolfo M, Radrizzani M, Fossati G, Parmiani G. Susceptibility of chemoresistant murine and human tumor cells to lysis by interleukin-2 activated lymphocytes. Cancer Res 1988; 48: 2372-6.
13. Shankaran V, Ikeda H, Bruce AT, White JM, Swanson PE, Old LJ, Schreiber RD. IFN-gamma and lymphocytes prevent primary tumor development and shape tumor immunogenicity. Nature 2001; 410: 1107-11.
14. + effector T cells mediate indirect interleukin-12 and interferon-γ-dependent suppression of autologous HLA-negative lung tumor xenografts in severe combined immunodeficient mice. Caner Res 2002; 62: 2611-7.
15. Chuang M, Lee MW, Zhao D, Severson DL. Metabolism of a long chain diacylglycerol by permeabilized A10 smooth muscle cells. Am J Physiol 1993; 265: C927-33.
16. 2+]i in freshly isolated mouse lymphocytes with in vivo priming. Immunol Letters 1999; 67: 23-30.
17. 2+ signaling". Biol Cell 2004; 96: 69-78.
18. Han SY, Cho SH, Kim SY, Seo JT, Moon SJ, Jhon GJ. Monoacetyldiglycerides as new Ca" mobilizing agents in rat pancreatic acinar cells. Bioorg Med Chem Lett 1999; 9: 59-64.
19. Goni FM, Alonso A. Structure and functional properties of diacylglycerols in membranes. Prog Lipid Res 1999; 38: 1-48.
20. Okamoto M, Sato M. Toll-like receptor signaling in anti-cancer immunity. J Med Invest 2003; 50: 9-24.